{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:28:24Z","timestamp":1795026504388,"version":"4.10.2"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The C-reactive to albumin ratio (CAR) integrates the pro-inflammatory and nutritional status of patients, which may provide superior prognostic information over either parameter alone in valvular heart disease (VHD). The study aims to examine the association between CAR and mortality and its ability as biomarker to guide risk stratification in VHD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>A total of 5519 patients (age \u226518\u00a0years) with moderate or severe VHD from a multicenter prospective cohort underwent echocardiography and CAR measurement. VHD examined included aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation; tricuspid regurgitation, and multi VHD. An optimal threshold of 0.15 was defined based on penalized splines and receiver operating characteristic curves. The primary outcome was all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The cohort had a mean age of 61.9\u00a0\u00b1\u00a013.7\u00a0years, and 2997 (54.3%) were men. At 2-year follow-up, 482 (8.7%) deaths occurred. Penalized splines showed a monotonic increase of relative hazards with greater CAR for death. Higher CAR was independently associated with mortality (overall adjusted hazard ratio [aHR]: 1.89; 95% confidence interval [CI]: 1.56\u20132.28;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and major adverse cardiovascular events (aHR: 1.40; 95% CI: 1.30\u20131.82;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Different subtypes of VHD incurred excess mortality with elevated CAR. Results remained consistent in patients under medical care. The CAR threshold combined with NT-proBNP amplified the stratification of patients at risk (log-rank,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). The addition of CAR to a prediction algorithm including traditional risk factors improved outcome prediction (continuous net reclassification index [NRI]: 0.57; likelihood ratio test\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and reclassified better in patients both with and without events (absolute NRI: 4.3%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>CAR provides incremental prognostic information for mortality in various VHD. It could aid in risk stratification as a dependable and accessible tracking tool of prognosis in VHDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000002576","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T12:01:16Z","timestamp":1748433676000},"page":"5245-5254","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Prognostic value of C-reactive protein to albumin ratio in patients with valvular heart disease: nationwide prospective cohort study"],"prefix":"10.1097","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5681-1812","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"},{"name":"Research Center, Institut Universitaire de Cardiologie et de Pneumologie de Que\u0301bec (Quebec Heart & Lung Institute), Universite\u0301 Laval, Que\u0301bec City, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"},{"name":"Research Center, Institut Universitaire de Cardiologie et de Pneumologie de Que\u0301bec (Quebec Heart & Lung Institute), Universite\u0301 Laval, Que\u0301bec City, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bincheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxing","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiao","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Medical Research & Biometrics Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Annick","family":"Clavel","sequence":"additional","affiliation":[{"name":"Research Center, Institut Universitaire de Cardiologie et de Pneumologie de Que\u0301bec (Quebec Heart & Lung Institute), Universite\u0301 Laval, Que\u0301bec City, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Pibarot","sequence":"additional","affiliation":[{"name":"Research Center, Institut Universitaire de Cardiologie et de Pneumologie de Que\u0301bec (Quebec Heart & Lung Institute), Universite\u0301 Laval, Que\u0301bec City, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runlin","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"R1-20261030","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jacc.2018.04.093","article-title":"Inflammatory pathways in CVD and diabetes","volume":"72","author":"Pareek","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R2-20261030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.amjcard.2022.10.001","article-title":"Role of \u03b2 blockers in inflammatory response during acute heart failure","volume":"186","author":"Davison","year":"2023","journal-title":"Am J Cardiol"},{"key":"R3-20261030","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/heartjnl-2022-321959","article-title":"Inflammatory proteomics profiling for prediction of incident atrial fibrillation","volume":"109","author":"B\u00f6rschel","year":"2023","journal-title":"Heart"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.imlet.2016.04.012","article-title":"Association study of inflammatory genes with rheumatic heart disease in North Indian population: a multi-analytical approach","volume":"174","author":"Gupta","year":"2016","journal-title":"Immunol Lett"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.arcmed.2007.03.011","article-title":"Metabolic syndrome and C-reactive protein among cardiology patients","volume":"38","author":"Chapidze","year":"2007","journal-title":"Archiv Med Res"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/5029853","article-title":"C-reactive protein and high-sensitive cardiac troponins correlate with oxidative stress in valvular heart disease patients","volume":"2022","author":"Jan","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"R7-20261030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.31083\/j.rcm.2019.03.524","article-title":"Serum albumin in patients undergoing transcatheter aortic valve replacement: a meta-analysis","volume":"20","author":"Hsieh","year":"2019","journal-title":"Rev Cardiovasc Med"},{"key":"R8-20261030","doi-asserted-by":"crossref","first-page":"e24785","DOI":"10.1097\/MD.0000000000024785","article-title":"Prognostic role of albumin level in heart failure","volume":"100","author":"El Iskandarani","year":"2021","journal-title":"Med (Baltimore)"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jjcc.2021.05.009","article-title":"The C-reactive protein to prealbumin ratio on admission and its relationship with outcome in patients hospitalized for acute heart failure","volume":"78","author":"Yamada","year":"2021","journal-title":"J Cardiol"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"e13550","DOI":"10.1111\/eci.13550","article-title":"The value of C-reactive protein-to-albumin ratio in predicting long-term mortality among HFrEF patients with implantable cardiac defibrillators","volume":"51","author":"\u00c7inier","year":"2021","journal-title":"Eur J Clin Investigation"},{"key":"R11-20261030","doi-asserted-by":"crossref","first-page":"ehac544.2076","DOI":"10.1093\/eurheartj\/ehac544.2076","article-title":"Long-term prognostic value of concomitant inflammation and malnutrition in patients undergoing valvular heart surgery","volume":"43","author":"Hung","year":"2022","journal-title":"Eur Heart J"},{"key":"R12-20261030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.21470\/1678-9741-2020-0482","article-title":"C-reactive protein to albumin ratio as a novel inflammatory-based marker for 30-day mortality in patients undergoing transcatheter aortic valve replacement","volume":"37","author":"Katkat","year":"2022","journal-title":"Braz J Cardiovasc Surg"},{"key":"R13-20261030","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R14-20261030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease","volume":"70","author":"Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R15-20261030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echo"},{"key":"R16-20261030","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jacc.2020.02.031","article-title":"Prognostic value of N-terminal Pro\u2013B-type natriuretic peptide in elderly patients with valvular heart disease","volume":"75","author":"Zhang","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R17-20261030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/ehjqcco\/qcac027","article-title":"Prognostic value of modified model for end-stage liver disease scores in patients with significant tricuspid regurgitation","volume":"9","author":"Lv","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"R18-20261030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12916-023-02971-y","article-title":"Assessment of cardio-renal-hepatic function in patients with valvular heart disease: a multi-biomarker approach\u2014the cardio-renal-hepatic score","volume":"21","author":"Lv","year":"2023","journal-title":"BMC Med"},{"key":"R19-20261030","doi-asserted-by":"crossref","first-page":"800961","DOI":"10.3389\/fcvm.2021.800961","article-title":"Prognostic impact of left ventricular ejection fraction in patients with moderate aortic regurgitation: potential implications for treatment decision-making","volume":"8","author":"Zhao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R20-20261030","doi-asserted-by":"crossref","first-page":"109084","DOI":"10.1016\/j.isci.2024.109084","article-title":"Prevalence and impact of diabetes in patients with valvular heart disease","volume":"27","author":"Lu","year":"2024","journal-title":"iScience"},{"key":"R21-20261030","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1097\/JS9.0000000000001268","article-title":"The STROCSS 2024 guideline: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"110","author":"Rashid","year":"2024","journal-title":"Int J Surg"},{"key":"R22-20261030","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.21037\/jtd-22-1157","article-title":"Development and validation of a new prediction model for calcific aortic valve stenosis","volume":"14","author":"Chen","year":"2022","journal-title":"J Thorac Dis"},{"key":"R23-20261030","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1586\/14779072.6.7.945","article-title":"New cardiovascular biomarkers: clinical implications in patients with valvular heart disease","volume":"6","author":"Moura","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R24-20261030","first-page":"523","article-title":"Prevalence and modifiable risk factors of degenerative valvular heart disease among elderly population in southern China","volume":"18","author":"He","year":"2021","journal-title":"J Geriatr Cardiol"},{"key":"R25-20261030","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.mayocp.2021.11.022","article-title":"C-reactive protein to albumin ratio in patients undergoing transcatheter aortic valve replacement","volume":"97","author":"Seoudy","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"R26-20261030","first-page":"101446","article-title":"Prevalence and prognostic significance of malnutrition risk in patients with valvular heart disease","volume":"4","author":"Li","year":"2025","journal-title":"JACC: Advances"},{"key":"R27-20261030","doi-asserted-by":"crossref","first-page":"ehac779.098","DOI":"10.1093\/eurheartj\/ehac779.098","article-title":"Prognostic value of longitudinal assessment of inflammatory and nutritional status in patients undergoing valvular heart surgery","volume":"44","author":"Hung","year":"2023","journal-title":"Eur Heart J"},{"key":"R28-20261030","doi-asserted-by":"crossref","first-page":"e024060","DOI":"10.1161\/JAHA.121.024060","article-title":"Concomitant hepatorenal dysfunction and malnutrition in valvular heart surgery: long-term prognostic implications for death and heart failure","volume":"11","author":"Tse","year":"2022","journal-title":"Jaha"},{"key":"R29-20261030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.14283\/jfa.2024.54","article-title":"Does a poor preoperative nutritional status impact outcomes of heart valve surgery?","volume":"13","author":"Pavone","year":"2024","journal-title":"J Frailty Aging"},{"key":"R30-20261030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjcard.2020.03.037","article-title":"Additive value of high-density lipoprotein cholesterol and C-reactive protein level assessment for prediction of 2-year mortality after transcatheter aortic valve implantation","volume":"126","author":"Zieli\u0144ski","year":"2020","journal-title":"Am J Cardiol"},{"key":"R31-20261030","first-page":"519","article-title":"Transcatheter aortic valve implantation and morbidity and mortality-related factors: a 5-year experience in Brazil","volume":"106","author":"Souza","year":"2016","journal-title":"Arq Bras Cardiol"},{"key":"R32-20261030","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jacc.2007.07.064","article-title":"Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease","volume":"50","author":"Novaro","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R33-20261030","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(01)01484-X","article-title":"C-reactive protein is increased in patients with degenerative aortic valvular stenosis","volume":"38","author":"Galante","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R34-20261030","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1681\/ASN.V1291927","article-title":"Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients","volume":"12","author":"Wang","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R35-20261030","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/eurheartj\/ehs002","article-title":"Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation","volume":"33","author":"Sinning","year":"2012","journal-title":"Eur Heart J"},{"key":"R36-20261030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.amjcard.2021.09.044","article-title":"Relation of serum albumin levels to myocardial extracellular volume in patients with severe aortic stenosis","volume":"163","author":"Shiyovich","year":"2022","journal-title":"Am J Cardiol"},{"key":"R37-20261030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijcard.2005.04.030","article-title":"Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP)","volume":"109","author":"Chiu-Braga","year":"2006","journal-title":"Int J Cardiol"},{"key":"R38-20261030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.amjcard.2011.11.010","article-title":"Relation of left atrial spontaneous echocardiographic contrast in patients with mitral stenosis to inflammatory markers","volume":"109","author":"Kaya","year":"2012","journal-title":"Am J Cardiol"},{"key":"R39-20261030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1542-474X.2007.00198.x","article-title":"High sensitivity CRP levels predict atrial tachyarrhythmias in rheumatic mitral stenosis","volume":"13","author":"Ucer","year":"2008","journal-title":"Noninvasive Electrocardiol"},{"key":"R40-20261030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijcard.2020.12.053","article-title":"Elevated C-reactive protein is significantly associated with left ventricular dysfunction in patients with aortic regurgitation and concomitant collagen disease","volume":"328","author":"Usuku","year":"2021","journal-title":"Int J Cardiol"},{"key":"R41-20261030","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.repc.2014.03.014","article-title":"High levels of high-sensitivity C-reactive protein and uric acid can predict disease severity in patients with mitral regurgitation","volume":"33","author":"Turker","year":"2014","journal-title":"Rev Port Cardiol"},{"key":"R42-20261030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/clc.22900","article-title":"Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip)","volume":"41","author":"D\u00f6rr","year":"2018","journal-title":"Clin Cardiol"},{"key":"R43-20261030","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000099057","article-title":"Impact of serum C-reactive protein elevation on the left ventricular spherical change and the development of mitral regurgitation after anterior acute myocardial infarction","volume":"107","author":"Kohno","year":"2007","journal-title":"Cardiology"},{"key":"R44-20261030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/ehjci\/jead009","article-title":"A streamlined, machine learning-derived approach to risk-stratification in heart failure patients with secondary tricuspid regurgitation","volume":"24","author":"Heitzinger","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R45-20261030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00246-012-0429-y","article-title":"Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission","volume":"34","author":"Lin","year":"2013","journal-title":"Pediatr Cardiol"},{"key":"R46-20261030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ejhf.2809","article-title":"Association between serum albumin and outcomes in heart failure and secondary mitral regurgitation: the COAPTtrial","volume":"25","author":"Feng","year":"2023","journal-title":"European J of Heart Fail"},{"key":"R47-20261030","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1093\/eurheartj\/ehac209","article-title":"Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational research programme valvular heart disease II survey","volume":"43","author":"Tribouilloy","year":"2022","journal-title":"Eur Heart J"},{"key":"R48-20261030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12872-021-02154-8","article-title":"Current status and etiology of valvular heart disease in China: a population-based survey","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"R49-20261030","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk","volume":"119","author":"Hlatky","year":"2009","journal-title":"Circulation"},{"key":"R50-20261030","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.2017.12126","article-title":"Discrimination and calibration of clinical prediction models","volume":"318","author":"Alba","year":"2017","journal-title":"Jama"},{"key":"R51-20261030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4244\/EIJ-D-18-00059","article-title":"Combination of high-sensitivity C-reactive protein with logistic EuroSCORE improves risk stratification in patients undergoing TAVI","volume":"14","author":"Stundl","year":"2018","journal-title":"EuroIntervention"},{"key":"R52-20261030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"R53-20261030","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacc.2023.05.061","article-title":"ACC\/AHA and ESC\/EACTS guidelines for the management of valvular heart diseases","volume":"82","author":"Coisne","year":"2023","journal-title":"J Am Coll Cardiol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000002576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:04:49Z","timestamp":1793351089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000002576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002576","relation":{},"ISSN":["1743-9159","1743-9191"],"issn-type":[{"value":"1743-9159","type":"electronic"},{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"2024-11-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}